Live Breaking News & Updates on Axsome Therapeutics

Stay updated with breaking news from Axsome therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bellevue Group AG Raises Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)

Bellevue Group AG increased its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 0.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 635,372 shares of the company’s stock after purchasing an additional 3,885 shares during the quarter. Bellevue Group AG owned 1.34% […] ....

United States , Markl Jacobson , Mark Coleman , Robertw Baird , Wealth Group , Affinity Asset Advisors , Royal Bank , Axsome Therapeutics Inc , Exchange Commission , Td Asset Management Inc , Bellevue Group , Lighthouse Investment Partners , Securities Exchange Commission , Axsome Therapeutics , Free Report , Investment Partners , Asset Advisors , Partners Asset Management , Management Inc , Director Mark Coleman , Therapeutics Trading Down , Get Free Report , Axsome Therapeutics Daily ,

Rhenman & Partners Asset Management AB Buys 39,000 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)

Rhenman & Partners Asset Management AB boosted its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 97.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 79,100 shares of the company’s stock after purchasing an additional 39,000 shares during the quarter. […] ....

United States , Roger Jeffs , Markl Jacobson , Axsome Therapeutics Inc , Washington Trust Advisors Inc , Sg Americas Securities , Cantor Fitzgerald , Royal Bank , Securities Exchange Commission , Morgan Stanley , Partners Asset Management , Axsome Therapeutics , Free Report , Trust Advisors , Ivy Capital Management , Aigen Investment Management , Director Roger Jeffs , Exchange Commission , Get Free Report , Visit Holdingschannel , Axsome Therapeutics Daily ,

Insider Selling: Axsome Therapeutics, Inc. (NASDAQ:AXSM) Director Sells 5,249 Shares of Stock

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) Director Mark Coleman sold 5,249 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $75.21, for a total value of $394,777.29. Following the completion of the transaction, the director now directly owns 19,848 shares in […] ....

United States , Mark Coleman , Axsome Therapeutics Inc , Rafferty Asset Management , Axsome Therapeutics Company Profile , Principal Financial Group Inc , Morgan Stanley , Securities Exchange Commission , Wealth Group , Royal Bank , Axsome Therapeutics , Get Free Report , Director Mark Coleman , Exchange Commission , Financial Group , Asset Management , Amalgamated Bank , Axsome Therapeutics Daily ,

Axsome Therapeutics to Participate in Upcoming Investor Conferences

Axsome Therapeutics to Participate in Upcoming Investor Conferences
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Miami Beach , Herriot Tabuteau , William Blair , Mark Jacobson , Darren Opland , Goldman Sachs , Loews Chicago Hotel , Drug Administration , World Trade Center , Axsome Therapeutics Inc , Corporate Communications , Annual Growth Stock Conference , Chief Executive Officer , Annual Global Healthcare Conference , Loews Miami Beach , Axsome Therapeutics ,